8-K: Ainos Amends Patent Licensing Deal with TCNT

Ainos, Inc. and Taiwan Carbon Nano Technology Corporation (TCNT) amended their product development agreement, setting a new patent licensing fee of $50,000 per month for two years.

Summary

• Ainos, Inc. and Taiwan Carbon Nano Technology Corporation (TCNT) entered into the Fourth Addendum to their Product Development Agreement on October 15, 2025.
• The amendment establishes a fee for the exclusive use of patents at $50,000 per month, plus 5% sales tax.
• This new fee structure is for a two-year period, commencing on October 16, 2025.
• This new two-year term replaces a previous one-year term that began on October 16, 2024.
• The parties may negotiate future payment terms and subsequent licensing methods after this two-year period.
• TCNT maintains control over Ainos, Inc. through its majority interest in Ainos KY and direct ownership, with Ainos KY holding majority voting power.

Sentiment

Score: 5

Explanation: The filing is a factual report of an amendment to an existing agreement, providing no explicit positive or negative financial performance indicators or strategic shifts that would significantly alter sentiment. It details a recurring cost within a related-party structure.

Positives

• Secures exclusive patent use for a two-year period, providing stability for co-development efforts.

Negatives

• Commits Ainos, Inc. to a recurring fee of $50,000 per month plus 5% sales tax for patent use.
• The related-party nature of the transaction means TCNT, the controlling entity, directly benefits from these fees.

Risks

• Reliance on TCNT for product development and patent licensing, given TCNT's controlling interest in Ainos, Inc.
• Future negotiations for payment terms and licensing methods after the two-year period introduce potential uncertainty regarding ongoing costs and access to intellectual property.

Future Outlook

The parties anticipate negotiating payment terms and subsequent licensing methods for patent use after the current two-year period concludes.

Related Party Transactions

• Ainos, Inc. and TCNT are related parties, with TCNT controlling Ainos, Inc. through its majority interest in Ainos KY and direct ownership. The Fourth Addendum Agreement for patent licensing is a related party transaction.

Stakeholder Impact

• Shareholders: Impacted by the recurring patent licensing fee and the ongoing financial relationship with TCNT, which is a controlling entity.
• Customers: Potential indirect impact on product development timelines and costs, though not explicitly detailed.

Next Steps

• Negotiation of payment terms and subsequent licensing methods for patent use after the two-year period ending October 15, 2027.

Key Dates

Recommendation

The filing details a routine amendment to an existing product development agreement, establishing a recurring patent licensing fee. Without further context on the previous fee structure or the financial materiality of this change relative to the company's overall operations, there are no clear signals to warrant a change from a 'hold' position. The ongoing related-party control by TCNT remains a key structural element.

Keywords

Ainos Inc., Taiwan Carbon Nano Technology Corporation, TCNT, Product Development Agreement, Patent Licensing, SEC Filing, 8-K, Pharmaceutical, Medical Device, Corporate Governance